Ipsen and Sutro Biopharma entered a global licensing deal for STRO-003, an ADC targeting ROR1, overexpressed in cancers, ...

is also one of the first antibodies recruited by the immune system to fight infection. IgM populations rise very quickly when the body is first confronted with an infectious organism, and then they ...

There are several types of antibodies, and IgG antibodies are associated with chronic (long-term) disease or long-term response to an infection. Normally, the body has minimal or undetectable levels ...

The therapeutic candidate is a bi-specific T cell engager IgM antibody targeting CD20 and CD3. It is being developed based on IgM antibody technology. The drug candidate was also under the development ...

Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby providing protection. But Scripps Research scientists have now discovered that for some HIV ...

Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby providing protection. Scientists at Scripps Research have now made a new discovery for some ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

IGM Biosciences Background Information (This ... their inherent properties may provide advantages as compared to IgG antibodies. Fintel is one of the most comprehensive investing research ...

On the other hand, to demonstrate the superiority of IgM antibody, two chimeric antibodies: 20-IgM (based on M20) and its IgG isotype 20-IgG were constructed for comparison. Although targeting the ...